<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23316">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01825213</url>
  </required_header>
  <id_info>
    <org_study_id>2013P000042</org_study_id>
    <nct_id>NCT01825213</nct_id>
  </id_info>
  <brief_title>Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT</brief_title>
  <official_title>Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve stratification of patients with chronic liver
      disease through non-invasive detection and characterization of small liver tumors and liver
      fibrosis by means of using multi spectral CT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a type IV phase study, in which an FDA approved imaging device currently used for
      studying chronic liver disease has not yet been validated.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Detection of hepatocellular carcinoma on Multi Spectral CT</measure>
    <time_frame>confirmation with focal biopsy and or/contrast-enhanced MRI of the liver acquired within 6 months prior to the multi spectral CT scan.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Liver Disease.</condition>
  <condition>Hepatocellular Carcinoma.</condition>
  <condition>Liver Fibrosis.</condition>
  <arm_group>
    <arm_group_label>Multispectral CT of the liver</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>images of lesions and liver will be compared to histology.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multispectral CT of the liver</intervention_name>
    <description>Analysis of the background liver and liver lesions will be performed on Multi Spectral CT images and compared to histology.</description>
    <arm_group_label>Multispectral CT of the liver</arm_group_label>
    <other_name>Discovery CT 750 HD, K120833</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patient undergoing CT scan for/suspicion of hepatocellular carcinoma.

          -  Patients should be scheduled for/or should have obtained a multiphasic MRI of the
             liver.

        Exclusion Criteria:

          -  patients &lt; 18 years old.

          -  history of allergy to intravenous contrast.

          -  patients at risk for contrast-induced-nephropathy,

          -  pregnant patients.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dushyant V Sahani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director of CT, Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jorge M Fuentes Orrego, MD</last_name>
    <phone>617 726 8386</phone>
    <email>jmfuentes@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Massachusetts General Hospital,</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge M Fuentes Orrego, MD</last_name>
      <phone>617-726-8386</phone>
      <email>jmfuentes@partners.org</email>
    </contact>
    <investigator>
      <last_name>Dushyant V Sahani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge M Fuentes Orrego, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sheela Agarwal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Koichi Hayano, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dhananjay Shirgavi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 25, 2013</lastchanged_date>
  <firstreceived_date>April 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Dushyant V. Sahani</investigator_full_name>
    <investigator_title>Director of CT, Associate Professor of Radiology Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>Liver disease</keyword>
  <keyword>Multi Spectral CT</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
